Bright key facts / Emerging
Legato puts hearing assistance in eyeglass frames. The tradeoffs matter.
Legato says its U.S. launch pairs on-frame speech processing with open-ear audio and prescription-lens options. Listed prices start at $999; listening, fit and availability will determine its usefulness.
- AI’s role
- Legato says SpeechSense uses an on-device neural network to separate speech from background noise and enhance it in real time. Open-ear speakers deliver the sound. The company says processing happens on the frames, with no camera or audio recording. These are manufacturer descriptions, not a Bright privacy audit or measured listening result.
- Documented result
- Legato announced its U.S. launch on October 1 at 09:00 Eastern. Its product pages checked October 2 list Symphony and Harmony at $999 and Aria at $1,099, before any separately priced lens options. The frames support prescription lenses and Bluetooth music and calls on iOS and Android. Product pages advertise more than ten hours of power; that is a manufacturer specification. The announcement establishes a product launch, not an observed improvement in everyday conversations. On October 2, between 18:39:42 and 18:39:49 Eastern, Bright rechecked Symphony Narrow/Matte Black, Harmony Medium/Matte Black and Aria Medium/Classic Tortoise. Each default product page displayed “Select Lenses.” After choosing nonprescription lenses with the free clear basic hardcoat, each review screen displayed “Add to Cart”; no “Sold Out” or “Notify me” message was visible in those checked flows. These are interface observations, not confirmed inventory or delivery. Bright did not add an item to a cart or place an order, and the check does not cover other variants or retailers.
- Important limitation
- Emerging evidence: the checked material establishes an announced product and manufacturer specifications. Bright has no hands-on evaluation, clinical outcome study or observed long-term user result.